OpenLegislation

Paragraph 11 F1

For the purposes of regulation 13 of these Regulations, essential use derogations granted by the Commission before F2IP completion day (under either Regulation 1062/2014 or its predecessor Regulation 1451/2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market) are deemed to have been granted by the Secretary of State subject to the same terms and conditions.

Annotations

Textual amendments

F1

Sch. 2 para. 11 inserted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 28(b); 2020 c. 1, Sch. 5 para. 1(1)

F2

Words in Sch. 2 para. 11 substituted (1.11.2022) by The Chemicals (Health and Safety) Trade and Miscellaneous Amendments Regulations 2022 (S.I. 2022/1037), regs. 1(2), 13(4)